Neuronetics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for STIM, updated each market day.
STIM AI Sentiment
AI predicts Neuronetics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Neuronetics, Inc. Common Stock
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Sector
Exchange
Market Cap
$95,601,698
Cap Tier
Employees
658
Headquarters
MALVERN, PA
Listed Since
June 28, 2018
Website
STIM Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
STIM Volatility
Neuronetics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
